| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/12/2007 | CN100353943C Fleroxacin lactate dispersion tablet, and its prepn. method |
| 12/12/2007 | CN100353942C Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
| 12/12/2007 | CN100353941C Medicinal composition contg. isoandrographolide and its medicinal use |
| 12/12/2007 | CN100353940C Tea active monomer composition and its application in prevention and treatment of tumor |
| 12/12/2007 | CN100353939C Antidepressant composition containing citalopram and cyclodextrin |
| 12/12/2007 | CN100353938C Composition containing dicaffeoyl quinic acid and its preparing method |
| 12/12/2007 | CN100353937C Agents for fattening animals |
| 12/12/2007 | CN100353936C Ferulaic acid sodium transfusion and prescription and preparation thereof |
| 12/12/2007 | CN100353935C Pharmaceutical formulation contg. tolterodine and its use |
| 12/12/2007 | CN100353933C Instant oral medincinal preparation |
| 12/12/2007 | CN100353866C Stimulation of in vivo production of proteins with formulation comprising leucine |
| 12/12/2007 | CN100353864C Chitin sauce food and its preparation method |
| 12/12/2007 | CA2577762A1 Ccr5 antagonist for enhancing immune reconstitution and treating opportunistic infection in hiv patients |
| 12/11/2007 | US7307176 Inclusion complex of taxol with 2-hydroxypropyl-beta-cyclodextrin |
| 12/11/2007 | US7307172 7-amino triazolopyrimidines for controlling harmful fungi |
| 12/11/2007 | US7307166 8-Substituted purines; ring-cleaved aldose (guanosine 2',3' dialcohol); inflammatory diseases and bacterial infections; modifying hematopoiesis in animals with damage caused by irradiation, chemotherapy, poisoning; improve host leukocyte-mediated defenses against infection. |
| 12/11/2007 | US7307164 β-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 12/11/2007 | US7307157 Process for producing chitin derivatives and/or chitosan derivatives having a crosslinked structure |
| 12/11/2007 | US7307156 Crystal forms of azithromycin |
| 12/11/2007 | US7307103 Sodium dodecyl sulfate compositions for inactivating prions |
| 12/11/2007 | US7307102 Administering selective estrogen receptor modulators that possesses tissue-specific ER agonist activity |
| 12/11/2007 | US7307101 Administering N-hydroxy-N-(4-butyl-2-methylphenyl)-formamidine (HET0016) to increase or prevent a decrease in cerebral blood flow |
| 12/11/2007 | US7307100 2-Benzoylchromone derivatives |
| 12/11/2007 | US7307099 Thioredoxin/thioredoxin reductase inhibitors, antiproliferative agents, anticancer agents |
| 12/11/2007 | US7307098 Indole derivatives and drugs containing the same |
| 12/11/2007 | US7307097 Chemical compounds |
| 12/11/2007 | US7307096 For intraocular pressure lowering action; for therapy and prophylaxis |
| 12/11/2007 | US7307095 Osteoporosis; antiarthritic agents; antidiabetic agents; antiinflammatory agents; Alzheimer's disease; shock; central nervous stsrem disorders; anticancer agents; multiple sclerosis, (S)-2-(Benzooxazol-2-ylamino)-3-cyclohexyl-N-[2-(5-fluoro-2,3-dihydro-indol-1-yl)-ethyl]-propionamide |
| 12/11/2007 | US7307094 Chemotherapy-induced nausea and vomiting (CINV), diarrhea-predominant Irritable Bowel Syndrome (IBS-D); 5-HT3 inhibitors; N-(1-Methylpiperidin-4-yl)-2-phenylbenzoxazole-4-carboxamide |
| 12/11/2007 | US7307093 Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof |
| 12/11/2007 | US7307092 Compounds Capable of Activating Cholinergic Receptors |
| 12/11/2007 | US7307091 Deuterated 3-piperidinopropiophenone and medicaments containing said compounds |
| 12/11/2007 | US7307090 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 12/11/2007 | US7307089 Central nervous system disorders, Parkinson's disease, Huntington's disease, anxiety, depression, manic depression, psychoses, epilepsy, obsessive compulsive disorders, mood disorders, migraine, Alzheimer's disease (enhancement of cognitive memory), sleep disorders, feeding disorders such as anorexia |
| 12/11/2007 | US7307088 Substituted anthranilic amide derivatives and methods of use |
| 12/11/2007 | US7307087 Antidepressants; analgesics; antiinflammatory agents; side effect reduction |
| 12/11/2007 | US7307086 3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors |
| 12/11/2007 | US7307085 Mitotic kinesin inhibitors |
| 12/11/2007 | US7307084 Gastric secretion inhibiting and excellent gastric and intestinal protective action properties, gastrointestinal disorder |
| 12/11/2007 | US7307083 Tetrahydro-acridine and dithiolane derivatives |
| 12/11/2007 | US7307082 Heterocyclic derivatives as CRF antagonists |
| 12/11/2007 | US7307081 Treatment of Human Immunodeficiency Virus, organ transplant rejection, graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis. |
| 12/11/2007 | US7307080 Nuclear enzyme poly(adenosine 5'-diphospho-ribose) polymerase inhibitors; protection against ill effects of reactive free radicals and nitric oxide |
| 12/11/2007 | US7307079 Treating acute and chronic pain and inflammatory, gastrointestinal, allergic, cardiovascular, skin, opthalmological, respiratory, nervous system, cognition and memory disorders, etc. |
| 12/11/2007 | US7307078 Polycyclic compounds which modulate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 12/11/2007 | US7307077 Heterocyclic compound and antitumor agent containing the same as effective ingredient |
| 12/11/2007 | US7307076 Beta agonists for the treatment of respiratory diseases |
| 12/11/2007 | US7307075 Tetrahydroquinoline analogues as muscarinic agonists |
| 12/11/2007 | US7307074 Diazepan derivatives or salts thereof |
| 12/11/2007 | US7307073 Benzoxazepines derivatives and their use as AMPA receptor stimulators |
| 12/11/2007 | US7307072 Prepared by mixing a lower hydrate of Cefdiner with an aqueous carrier; kits with instructions to mix with water for administration; storage stability |
| 12/11/2007 | US7307071 RAF-MEK-ERK pathway inhibitors to treat cancer |
| 12/11/2007 | US7307070 Microbicidal compositions |
| 12/11/2007 | US7307069 Inflammatory diseases and cancers; promotion of apoptosis; may have phosphorothioate, 2'-O-(2-methoxyethyl) sugar, and/or 5-methyl cytosine modifications; useful prophylactically, and as clinical research and diagnostic tools. |
| 12/11/2007 | US7307068 Use of rapamycin to inhibit immune response and induce tolerance to gene therapy vector and encoded transgene products |
| 12/11/2007 | US7307067 Methods and compositions for reducing viral genome amounts in a target cell |
| 12/11/2007 | US7307065 Therapy for hepatitis B virus infection ; antiproliferative agents; antitumor agents; anticancer agents |
| 12/11/2007 | US7307062 such as anxiety disorder, attention deficit/hyperactivity disorder, autistic disorder, bipolar disorder, major depression, mood disorder, pervasive developmental disorder, psychotic disorder and schizophrenia by administering an antimicrobial composition optionally with a probiotic mixture |
| 12/11/2007 | US7306950 Composition and use of substances for stabilising amino acids containing sulphur |
| 12/11/2007 | US7306945 Fragment of alpha-synuclein is contacted with a drug; reduction in the rate or extent of aggregation fragment of alpha-synuclein relative to a control lacking the agent indicates the agent has the pharmacological activity |
| 12/11/2007 | US7306920 Gene associated with regulation of energy balance, obesity and diabetes and uses therefor |
| 12/11/2007 | US7306903 Use of test cells comprising DNA defining a morphogen-responsive transcription activating element operatively associated with reporter gene, increase in expression of detectable gene product after exposing test cell to candidate compound indicates ability of compound to induce morphogen-mediated effect |
| 12/11/2007 | US7306817 Herbal composition for treating CD33+ acute and chronic myeloid leukemia and a method thereof |
| 12/11/2007 | US7306815 Compositions enriched in phenolic compounds and methods for producing the same |
| 12/11/2007 | US7306804 HIV-specific T-cell induction |
| 12/11/2007 | US7306802 Ophthalmic compositions containing a synergistic combination of three polymers |
| 12/11/2007 | US7306797 Use of a compound antagonist of ESM-1 protein for producing a medicine for treating cancer |
| 12/11/2007 | US7306789 Method of stimulating hair growth using benzopyrans |
| 12/11/2007 | CA2420766C Trace elements |
| 12/11/2007 | CA2413510C Condensed pyrazindione derivatives |
| 12/11/2007 | CA2405822C Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof |
| 12/11/2007 | CA2393271C Retroviral protease inhibiting compounds |
| 12/11/2007 | CA2370202C Gum pad for delivery of medication to mucosal tissues |
| 12/11/2007 | CA2348735C Heterocyclic potassium channel inhibitors |
| 12/11/2007 | CA2348245C Treatment of rumen acidosis with .alpha.-amylase inhibitors |
| 12/11/2007 | CA2304661C Parenteral formulations comprising carbamazepine or its derivatives |
| 12/11/2007 | CA2289462C Intrauterine chemical necrosing method, composition, and apparatus |
| 12/11/2007 | CA2224426C Cis-9,10-octadecenoamidase |
| 12/11/2007 | CA2220019C Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation |
| 12/11/2007 | CA2184077C Nasal and ocular administration of ketamine to manage pain and for detoxification |
| 12/11/2007 | CA2171618C Purine nucleoside phosphorylase gene therapy for human malignancy |
| 12/11/2007 | CA2166003C Method for providing nutrition to the elderly patients |
| 12/08/2007 | CA2590995A1 Composition for prophylaxis or treatment of urinary system infection and method thereof |
| 12/06/2007 | WO2007140439A2 Compounds as cannabinoid receptor ligands and uses thereof |
| 12/06/2007 | WO2007140383A2 Spirocyclic sulfonamides and related compounds |
| 12/06/2007 | WO2007140333A2 Mononucleoside phosphonate compounds |
| 12/06/2007 | WO2007140297A2 Aziridinyl-epothilone compounds |
| 12/06/2007 | WO2007140285A2 Nebulizable compositions of quaternary ammonium muscarinic receptor antagonists |
| 12/06/2007 | WO2007140267A1 Barrier film-forming germicidal compostition for controlling mastitis |
| 12/06/2007 | WO2007140263A2 Macrophage migration inhibitory factor antagonists and methods of using same |
| 12/06/2007 | WO2007140254A2 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors |
| 12/06/2007 | WO2007140248A1 5(s)-(2'-hydroxyethoxy)-20(s)-camptothecin and its preparation and use for the treatment of cancer |
| 12/06/2007 | WO2007140239A1 Crystalline form of 5(s)-(2'-hydroxyethoxy)-20(s)-camptothecin |
| 12/06/2007 | WO2007140233A1 Inhibitors of polo-like kinases |
| 12/06/2007 | WO2007140228A2 Nicotine-alternative compositions and methods of producing such compositions |
| 12/06/2007 | WO2007140212A2 Tartrate salt of isofagomine and methods of use |
| 12/06/2007 | WO2007140197A1 Therapeutic pyrrolidine compounds |
| 12/06/2007 | WO2007140191A2 Glucose transport inhibitors and methods of use |
| 12/06/2007 | WO2007140189A2 Preparation and utility of substituted carboxylic acid compounds |
| 12/06/2007 | WO2007140184A2 Deoxynojirimycin and d-arabinitol analogs and methods of using |